Frost & Sullivan

Infertility treatment companies to benefit from untapped European markets

Published in Physician Law Weekly, October 12th, 2005

Even with 30 million cases of erectile dysfunction (ED) in Europe, the infertility drugs market has not taken off to the expected extent in the region.

The blame could lie largely with the conservative attitude regarding infertility among both men and women. While more than half the men over 40 years of age suffer from this disorder, only 10% to 15% seek treatment.

Drug companies can profit from these untapped markets by improving awareness in the target population. More men have already started consulting doctors, especially since ED is treatable at any stage.

There is also a high prevalence of ED in comorbid medical conditions...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly

Source: Physician Law Weekly (2005-10-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry